Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Epstein-Barr virus in nasopharyngeal and salivary gland carcinomas of Greenland Eskimoes.

Literature DB >> 6293523

Epstein-Barr virus in nasopharyngeal and salivary gland carcinomas of Greenland Eskimoes.

A K Saemundsen, H Albeck, J P Hansen, N H Nielsen, M Anvret, W Henle, G Henle, K A Thomsen, H K Kristensen, G Klein.

Abstract

Biopsy specimens from nasopharyngeal carcinomas (NPC) or salivary-gland carcinomas (SGC) in Greenland Eskimoes were examined for the presence of Epstein-Barr virus (EBV) DNA and sera from the patients were tested for EBV-specific antibody titres. Six out of 7 NPCs and one from an undifferentiated SGG were positive for EBV DNA. The EBV-specific antibody spectra and titres of the patients with NPC or undifferentiated SGG conformed to the results of earlier studies in other high-incidence areas.

Entities: Disease Species

Mesh：

Substances：

Year: 1982 PMID： 6293523 PMCID： PMC2011144 DOI： 10.1038/bjc.1982.264

Source DB: PubMed Journal: Br J Cancer ISSN： 0007-0920 Impact factor: 7.640

31 in total

1. Differences in EBV antibody titres of patients with nasopharyngeal carcinoma originating from high, intermediate and low incidence areas.

Authors: G de-The; M F Lavoue; L Muenz
Journal: IARC Sci Publ Date: 1978

2. Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells.

Authors: L J Old; E A Boyse; H F Oettgen; E D Harven; G Geering; B Williamson; P Clifford
Journal: Proc Natl Acad Sci U S A Date: 1966-12 Impact factor: 11.205

3. Nasopharyngeal carcinoma: significance of changes in Epstein-Barr virus-related antibody patterns following therapy.

Authors: W Henle; J H Ho; G Henle; J C Chau; H C Kwan
Journal: Int J Cancer Date: 1977-11-15 Impact factor: 7.396

4. Attempts to detect virus-specific DNA in human tumors. II. Nucleic acid hybridizations with complementary RNA of human herpes group viruses.

Authors: H zur Hausen; H Schulte-Holthausen; H Wolf; K Dörries; H Egger
Journal: Int J Cancer Date: 1974-05-15 Impact factor: 7.396

5. Association of Epstein-Barr virus with nasopharyngeal carcinoma in Alaskan native patients: serum antibodies and tissue EBNA and DNA.

Authors: A P Lanier; G W Bornkamm; W Henle; G Henle; T R Bender; M L Talbot; P H Dohan
Journal: Int J Cancer Date: 1981-09-15 Impact factor: 7.396

6. Identification of transcribed regions of Epstein-Barr virus DNA in Burkitt lymphoma-derived cells.

Authors: L Rymo
Journal: J Virol Date: 1979-10 Impact factor: 5.103

7. Cancer incidence in Alaska natives.

Authors: A P Lanier; T R Bender; W J Blot; J F Fraumeni; W B Hurlburt
Journal: Int J Cancer Date: 1976-10-15 Impact factor: 7.396

8. Nasopharyngeal carcinoma in Alaskan Eskimos Indians, and Aleuts: a review of cases and study of Epstein-Barr virus, HLA, and environmental risk factors.

Authors: A Lanier; T Bender; M Talbot; S Wilmeth; C Tschopp; W Henle; G Henle; D Ritter; P Terasaki
Journal: Cancer Date: 1980-11-01 Impact factor: 6.860

9. Relationship between the Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: correlated nucleic acid hybridization and histopathological examination.

Authors: M Andersson-Anvret; N Forsby; G Klein; W Henle
Journal: Int J Cancer Date: 1977-10-15 Impact factor: 7.396

10. MORPHOLOGICAL AND BIOLOGICAL STUDIES ON A VIRUS IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA.

Authors: M A EPSTEIN; G HENLE; B G ACHONG; Y M BARR
Journal: J Exp Med Date: 1965-05-01 Impact factor: 14.307

20 in total

1. Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands.

Authors: A Janz; M Oezel; C Kurzeder; J Mautner; D Pich; M Kost; W Hammerschmidt; H J Delecluse
Journal: J Virol Date: 2000-11 Impact factor: 5.103

2. Epstein-Barr virus (EBV) glycoprotein gp350 expressed on transfected cells resistant to natural killer cell activity serves as a target antigen for EBV-specific antibody-dependent cellular cytotoxicity.

Authors: M Khyatti; P C Patel; I Stefanescu; J Menezes
Journal: J Virol Date: 1991-02 Impact factor: 5.103

Review 3. Genotypic mapping of HPV and assessment of EBV prevalence in endocervical lesions.

Authors: J J O'Leary; R J Landers; M Crowley; I Healy; W F Kealy; J Hogan; C Cullinane; P Kelehan; C T Doyle
Journal: J Clin Pathol Date: 1997-11 Impact factor: 3.411

4. Sporadic EBV-associated lymphoepithelial salivary gland carcinoma with EBV-positive low-grade myoepithelial component.

Authors: Hermann Herbst; Gerald Niedobitek
Journal: Virchows Arch Date: 2006-03-01 Impact factor: 4.064

5. A clinical analysis of 37 cases with lymphoepithelial carcinoma of the major salivary gland treated by surgical resection and postoperative radiotherapy: a single institution study.

Authors: Fei Li; Guopei Zhu; Yulong Wang; Yu Wang; Tongzhen Chen; Qinghai Ji
Journal: Med Oncol Date: 2014-04-09 Impact factor: 3.064

6. Lymphoepithelioma-like esophageal carcinoma with macroscopic reduction.

Authors: Masaya Uesato; Tuguaki Kono; Tooru Shiratori; Yasunori Akutsu; Isamu Hoshino; Kentarou Murakami; Daisuke Horibe; Tetsurou Maruyama; Yoshihide Semba; Ryuma Urahama; Yukiko Ogura; Takashi Oide; Toru Tanizawa; Hisahiro Matsubara
Journal: World J Gastrointest Endosc Date: 2014-08-16